Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress.
Anxiety disorders are frequently long-lasting and debilitating for more than 40 million American adults. Although stressor exposure plays an important role in the etiology of some anxiety disorders, the mechanisms by which exposure to stressful stimuli alters central circuits that mediate anxiety-like emotional behavior are still unknown. Substantial evidence has implicated regions of the central extended amygdala, including the bed nucleus of the stria terminalis (BNST) and the central nucleus of the amygdala as critical structures mediating fear- and anxiety-like behavior in both humans and animals. These areas organize coordinated fear- and anxiety-like behavioral responses as well as peripheral stress responding to threats via direct and indirect projections to the paraventricular nucleus of the hypothalamus and brainstem regions (Walker et al. Eur J Pharmacol 463:199-216, 2003, Prog Neuropsychopharmacol Biol Psychiatry 33(8):1291-1308, 2009; Ulrich-Lai and Herman Nat Rev Neurosci 10:397-409, 2009). In particular, the BNST has been argued to mediate these central and peripheral responses when the perceived threat is of long duration (Waddell et al. Behav Neurosci 120:324-336, 2006) and/or when the anxiety-like response is sustained (Walker and Davis Brain Struct Funct 213:29-42, 2008); hence, the BNST may mediate pathological anxiety-like states that result from exposure to chronic stress. Indeed, chronic stress paradigms result in enhanced BNST neuroplasticity that has been associated with pathological anxiety-like states (Vyas et al. Brain Res 965:290-294, 2003; Pego et al. Eur J Neurosci 27:1503-1516, 2008). Here we review evidence that suggests that pituitary adenylate cyclase-activating polypeptide (PACAP) and corticotropin-releasing hormone (CRH) work together to modulate BNST function and increase anxiety-like behavior. Moreover, we have shown that BNST PACAP as well as its cognate PAC1 receptor is substantially upregulated following chronic stress, particularly in the BNST oval nucleus where PACAP-containing neurons closely interact with CRH-containing neurons (Kozicz et al. Brain Res 767:109-119, 1997; Hammack et al. Psychoneuroendocrinology 34:833-843, 2009). We describe how interactions between PACAP and CRH in the BNST may mediate stress-associated behaviors, including anorexia and anxiety-like behavior. These studies have the potential to define specific mechanisms underlying anxiety disorders, and may provide important therapeutic strategies for stress and anxiety management.
Hammack
Sayamwong E
SE
Department of Psychology, University of Vermont, Dewey Hall 334, Burlington, VT 05405, USA. sayamwong.hammack@uvm.edu
Roman
Carolyn W
CW
Lezak
Kimberly R
KR
Kocho-Shellenberg
Margaret
M
Grimmig
Bethany
B
Falls
William A
WA
Braas
Karen
K
May
Victor
V
D000818:Animals; D001007:Anxiety / Q000378:metabolism / Q000503:physiopathology; D001522:Behavior, Animal / Q000502:physiology*; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D006801:Humans; D009473:Neuronal Plasticity / Q000502:physiology; D009479:Neuropeptides / Q000378:metabolism; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000378:metabolism*; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / Q000378:metabolism; D012686:Septal Nuclei / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D013315:Stress, Psychological / Q000378:metabolism* / Q000503:physiopathology*
D009479:Neuropeptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; D003346:Corticotropin-Releasing Hormone
Eur J Pharmacol. 2003 Feb 28;463(1-3):199-216
12600711
Brain Res Mol Brain Res. 2000 Dec 8;84(1-2):79-89
11113534
Mol Pharmacol. 1999 Dec;56(6):1280-7
10570056
J Neurosci. 2003 Jan 1;23(1):23-8
12514197
J Neurochem. 2006 Oct;99(2):499-513
17029602
Endocr Rev. 2000 Feb;21(1):55-89
10696570
J Pharmacol Exp Ther. 1994 Sep;270(3):1282-8
7932180
Brain Res Dev Brain Res. 2000 Mar 15;120(1):27-39
10727727
Neural Plast. 2007;2007:79102
17641738
Neurosci Biobehav Rev. 2005 Jan;28(8):837-50
15642625
Adv Exp Med Biol. 2004;551:77-83
15602947
Br J Pharmacol. 2004 Sep;143(1):107-18
15302684
Behav Neurosci. 2006 Apr;120(2):324-36
16719697
J Neurochem. 2007 Feb;100(3):603-16
17181550
J Physiol. 2004 Feb 15;555(Pt 1):15-26
14608012
J Comp Neurol. 2001 Aug 6;436(4):430-55
11447588
Mol Psychiatry. 2007 Nov;12(11):1026-32
17387318
Biochem Biophys Res Commun. 1990 Jul 31;170(2):643-8
2383262
Brain Res. 1998 Nov 9;810(1-2):211-9
9813333
J Comp Neurol. 1989 Feb 22;280(4):603-21
2468695
Crit Rev Neurobiol. 1996;10(3-4):371-94
8978987
Bioorg Med Chem Lett. 2008 Mar 15;18(6):2162-6
18272364
Endocrinology. 1991 Nov;129(5):2787-9
1935809
Recept Channels. 2002;8(3-4):137-53
12529932
Endocrinology. 2002 Oct;143(10):3946-54
12239106
Nat Rev Neurosci. 2009 Jun;10(6):397-409
19469025
J Biol Chem. 1997 Aug 8;272(32):19666-71
9242621
J Comp Neurol. 1996 Aug 05;371(4):567-77
8841910
Neuroscience. 2004;128(1):7-14
15450349
Ann N Y Acad Sci. 1999 Jun 29;877:281-91
10415655
Neuroendocrinology. 1993 Mar;57(3):517-24
8391664
Peptides. 1997;18(10):1539-45
9437714
Neuron. 1992 Apr;8(4):811-9
1314625
Brain Res Mol Brain Res. 2005 Jul 29;138(1):45-57
15882914
J Neuroendocrinol. 1994 Aug;6(4):433-42
7987374
Psychopharmacology (Berl). 2002 Nov;164(3):318-28
12424556
Neuron. 1993 Aug;11(2):333-42
8394723
J Clin Psychiatry. 2009;70 Suppl 2:10-4
19371501
Ann N Y Acad Sci. 2006 Jul;1070:450-6
16888208
Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):78-84
11483244
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13355-60
11687615
J Clin Invest. 2000 May;105(9):1307-15
10792006
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1291-308
19595731
Psychoneuroendocrinology. 2009 Jul;34(6):833-43
19181454
Jpn J Physiol. 1998 Oct;48(5):301-31
9852340
Behav Neurosci. 2004 Apr;118(2):443-8
15113272
Neuroscience. 2006;138(1):235-43
16359808
Nature. 1993 Sep 9;365(6442):170-5
8396727
J Comp Neurol. 2002 Nov 25;453(4):389-417
12389210
J Neurosci. 1997 Aug 15;17(16):6434-46
9236251
Psychopharmacology (Berl). 2002 Jan;159(3):304-10
11862363
Biochem Biophys Res Commun. 1990 Jan 15;166(1):81-9
2302217
J Neurosci. 2004 Oct 6;24(40):8786-95
15470144
J Neurosci. 1997 Jan 1;17(1):83-90
8987738
Eur J Pharmacol. 2000 Jul 28;401(1):39-46
10915835
Peptides. 2007 Sep;28(9):1856-70
17512639
J Biol Chem. 2010 Mar 26;285(13):9749-9761
20093365
J Neurosci. 2003 Jan 1;23(1):12-6
12514195
Neuroscience. 2010 Feb 17;165(4):1025-30
19931358
Pharmacol Rev. 2009 Sep;61(3):283-357
19805477
Brain Res. 1987 Mar 31;407(2):327-31
3567648
Endocr Rev. 2000 Dec;21(6):619-70
11133067
Brain Res. 1999 Nov 27;848(1-2):141-52
10612706
Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R956-65
18184762
J Biol Chem. 1999 Aug 13;274(33):23103-10
10438479
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2679-83
8146174
J Biol Chem. 2003 Mar 14;278(11):9630-8
12524444
J Chem Neuroanat. 1991 Jul-Aug;4(4):281-98
1718318
Neuroscience. 2008 Apr 22;153(1):232-9
18343592
J Comp Neurol. 1997 Jul 7;383(3):305-25
9205043
J Comp Neurol. 2003 Dec 8;467(2):232-42
14595770
Am J Physiol Regul Integr Comp Physiol. 2004 Nov;287(5):R1194-201
15217792
Endocrinology. 1995 Sep;136(9):4116-24
7649120
BMC Neurosci. 2004 Sep 20;5:36
15380027
J Neurochem. 2009 Jul;110(2):595-602
19457081
Brain Res. 2003 Mar 7;965(1-2):290-4
12591150
Biol Psychiatry. 2005 Nov 15;58(10):796-804
16043132
J Comp Neurol. 2006 Aug 10;497(5):772-807
16786552
Behav Neurosci. 1988 Apr;102(2):233-43
3365319
Biochem Biophys Res Commun. 1993 Jul 15;194(1):133-43
7687425
Brain Res. 1994 Sep 19;657(1-2):141-9
7820612
FEBS Lett. 1993 Nov 8;334(1):3-8
8224221
Neurosci Lett. 1998 May 1;246(3):145-8
9792613
Behav Neurosci. 1986 Dec;100(6):814-24
3545257
Neurosci Lett. 2004 Apr 22;360(1-2):106-8
15082190
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Dec;27(8):1177-85
14659473
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1201-13
16271821
Brain Res Brain Res Rev. 2001 Dec;38(1-2):192-246
11750933
Mol Endocrinol. 2001 Oct;15(10):1739-47
11579206
J Comp Neurol. 1996 Dec 09;376(2):278-94
8951643
J Endocrinol. 1999 Jan;160(1):1-12
9854171
Psychoneuroendocrinology. 1998 Apr;23(3):219-43
9695128
Eur J Neurosci. 2008 Mar;27(6):1503-16
18336570
Neurosci Lett. 2010 Jan 14;468(3):300-2
19914336
Brain Res Bull. 1991 Aug;27(2):207-12
1742609
Neuroimage. 2007 Oct 1;37(4):1427-36
17681799
Biochem Biophys Res Commun. 1990 Dec 31;173(3):1271-9
2268329
J Physiol. 1995 May 1;484 ( Pt 3):721-36
7623287
Regul Pept. 2005 May 15;128(1):33-41
15721485
Schizophr Bull. 2011 Jul;37(4):811-21
19959704
Brain Res. 1997 Aug 29;767(1):109-19
9365022
J Neurosci. 2002 Aug 1;22(15):6810-8
12151561
Trends Neurosci. 1997 Feb;20(2):78-84
9023876
J Biol Chem. 1996 Sep 6;271(36):22146-51
8703026
J Comp Neurol. 1989 Feb 22;280(4):587-602
2708568
J Biol Chem. 1997 Jan 10;272(2):966-70
8995389
J Comp Neurol. 1999 Oct 11;413(1):113-28
10464374
Brain Struct Funct. 2008 Sep;213(1-2):29-42
18528706
Nat Genet. 1998 Jun;19(2):162-6
9620773
Biol Psychiatry. 2003 Feb 15;53(4):275-83
12586446